Literature DB >> 26610652

Relationship of high leptin levels with an adverse lipid and insulin profile in 6-8 year-old children in Spain.

A Jois1, P Navarro1, H Ortega-Senovilla2, T Gavela-Pérez3, L Soriano-Guillén3, C Garcés4.   

Abstract

BACKGROUND AND AIMS: Leptin, an adipokine elevated in obesity, may be related to an adverse cardiovascular risk profile in childhood. However, evidence for this relationship in pre-pubertal children is scarce. We aimed to analyze the relationship between leptin levels and lipid and insulin profiles in Spanish children. METHODS AND
RESULTS: Our population-based sample included 389 males and 369 females aged 6-8 years. Lipid levels were determined by standard methods, insulin by radioimmunoassay and leptin by sandwich ELISA. Leptin levels were higher in girls (8.6 ng/ml) than boys (4.7 ng/ml) (p < 0.001). Leptin increased from ages 6 to 8 in girls, but remained steady in boys. In both sexes, leptin increased significantly (p < 0.001) across weight category from normal weight to obese. Children in the highest tertile of leptin concentration showed significantly (p < 0.01) lower levels of HDL-cholesterol (HDL-C) and apolipoprotein-AI (apo-AI) and significantly higher triglyceride (TG) levels than children in lower tertiles. However, in linear regression analysis, after adjustment for body mass index (BMI), leptin only accounted for 1.5% of the variance of HDL-C in boys, and 2.6% of the variance of apo-AI in girls. Leptin was strongly and positively correlated with insulin and HOMA. Upon regression analysis, leptin contributed to over 20% of the variability in insulin and HOMA, independent of BMI.
CONCLUSION: Leptin levels show sex differences in pre-pubertal children. In this age group, leptin levels are strongly related to insulin, and affect lipid profile -namely HDL-C, apo-AI and TG- particularly when leptin levels are high.
Copyright © 2015 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6–8 year-old children; HDL-Cholesterol; Insulin; Leptin; TG; apo-AI

Mesh:

Substances:

Year:  2015        PMID: 26610652     DOI: 10.1016/j.numecd.2015.09.005

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  5 in total

1.  Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence.

Authors:  Ling-Jun Li; Sheryl L Rifas-Shiman; Izzuddin M Aris; Christos Mantzoros; Marie-France Hivert; Emily Oken
Journal:  Metabolism       Date:  2018-11-07       Impact factor: 8.694

2.  Pro- and anti-inflammatory adipokines are associated with cardiometabolic risk markers in Brazilian schoolchildren.

Authors:  Mariana De Santis Filgueiras; Milene Cristine Pessoa; Josefina Bressan; Fernanda Martins de Albuquerque; Lara Gomes Suhett; Mariane Alves Silva; Juliana Farias de Novaes
Journal:  Eur J Pediatr       Date:  2021-04-09       Impact factor: 3.183

3.  Vegetable and Fruit Intakes Are Associated with hs-CRP Levels in Pre-Pubertal Girls.

Authors:  Pilar Navarro; Olaya de Dios; Asha Jois; Teresa Gavela-Pérez; Lydia Gorgojo; José M Martín-Moreno; Leandro Soriano-Guillen; Carmen Garcés
Journal:  Nutrients       Date:  2017-03-02       Impact factor: 5.717

4.  Sex-Dependent Mediation of Leptin in the Association of Perilipin Polymorphisms with BMI and Plasma Lipid Levels in Children.

Authors:  Claudia Vales-Villamarín; Jairo Lumpuy-Castillo; Teresa Gavela-Pérez; Olaya de Dios; Iris Pérez-Nadador; Leandro Soriano-Guillén; Carmen Garcés
Journal:  Nutrients       Date:  2022-07-26       Impact factor: 6.706

5.  The associations between some biological markers, obesity, and cardiovascular risk in Slovenian children and adolescents.

Authors:  Nataša Marčun Varda; Martina Medved; Laura Ojsteršek
Journal:  BMC Pediatr       Date:  2020-02-21       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.